Segunda línea en cáncer de pulmón de células no - page 36

Checkpoint inhibitors in metastatic EGFR mutated NSCLC
cancer. A meta-analysis
Khoon C, et al. J Thorac Oncol 2016
1...,26,27,28,29,30,31,32,33,34,35 37,38,39,40,41
Powered by FlippingBook